Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention
1 other identifier
interventional
46
1 country
1
Brief Summary
The purpose is to investigate possible mechanisms of increased blood lipid levels following transplantation, and also to see if a comprehensive dietary intervention is effective in reducing blood lipid levels in post-transplant patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Nov 2005
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 22, 2009
CompletedFirst Posted
Study publicly available on registry
July 28, 2009
CompletedJuly 28, 2009
July 1, 2009
3.6 years
July 22, 2009
July 24, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cholesterol and fatty acid synthesis
Pre-transplant, post-transplant (>3 months after transplant, up to 2 years) and post-dietary intervention (1 month after post-transplant measurement)
Secondary Outcomes (1)
Blood lipid levels
Pre-transplant, post-transplant (>3 months after transplant, up to 2 years) and post-dietary intervention (1 month after post-transplant measurement)
Study Arms (3)
Islet transplant
EXPERIMENTALPeople with Type 1 diabetes undergoing islet transplantation
Liver transplant
EXPERIMENTALPeople with liver failure undergoing liver transplantation
Control
EXPERIMENTALHealthy normal people which serve as control group
Interventions
Supplement bar \& spread formulated with key nutrients (fish oil, phytosterols, almonds, soy protein) shown to help in reducing blood lipid levels
Eligibility Criteria
You may qualify if:
- on islet or liver transplant list
- post-transplant \>3 months
- physically able to participate in study and intervention
You may not qualify if:
- \< 18 years of age
- family history of premature cardiovascular disease or familial hyperlipidemia (control subjects)
- cholestatic diseases (liver transplant patients)
- type 2 diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alberta
Edmonton, Alberta, T6G 2P5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael T Clandinin, PhD
University of Alberta
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 22, 2009
First Posted
July 28, 2009
Study Start
November 1, 2005
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
July 28, 2009
Record last verified: 2009-07